The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
about
Emerging drugs for uveitisTregalizumab - A Monoclonal Antibody to Target Regulatory T CellsAnkylosing spondylitis: A state of the art factual backboneThe TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspiratorAnti-TNF therapy for juvenile idiopathic arthritis-related uveitisManagement of noninfectious posterior uveitis with intravitreal drug therapyNovel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune DiseasesInfliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation.Tumor necrosis factor alpha is a promising circulating biomarker for the development of obstructive sleep apnea syndrome: a meta-analysis.TNF-α Antagonist and Infection in Rheumatoid Arthritis.Effects of hyaluronic acid conjugation on anti-TNF-α inhibition of inflammation in burnsEffectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatmentSystemic therapies for inflammatory eye disease: past, present and futureTherapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trialSalivary markers of inflammation in response to acute stress.Diagnostic techniques for inflammatory eye disease: past, present and future: a review.17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.The human condition: an immunological perspective.Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelinationConstitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation.Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patientsModulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoidThe antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system.Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuliSafety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial.Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis.Serum Levels of IL-6 and TNF-α May Correlate with Activity and Severity of Rheumatoid Arthritis.Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.IL-7- and IL-15-mediated TCR sensitization enables T cell responses to self-antigens.Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexateRole of the retinal vascular endothelial cell in ocular diseasePathophysiological Significance of Hepatic ApoptosisThe christchurch earthquake: crush injury, neuropathic pain, and posttraumatic stress disorderTargeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network.Certolizumab in the long-term treatment of rheumatoid arthritis.In Vitro TNF-α Inhibitory Activity of Brazilian Plants and Anti-Inflammatory Effect of Stryphnodendron adstringens in an Acute Arthritis Model.An anti-TNF-α antibody mimetic to treat ocular inflammation.
P2860
Q24630848-18460976-11E6-44BD-9563-4A7616C8B909Q26772699-BCF9EAA9-FE05-453A-8CFE-5D2F0FD3F69CQ26782184-C1326085-F362-4687-9801-AB176FDA0D81Q26799347-D12BDC64-A318-4742-A2B3-F8FFC95F0B28Q26849811-DE786BC6-941B-4B15-BB40-B002966F78F5Q28074741-994DB7E7-8B58-4319-B597-C5D5A4D4CBF2Q28552664-583ED872-D31D-454D-BC67-571E9C23533DQ33562586-71DFE0ED-7717-4D6A-B42C-524C0D60EB81Q33584492-0DAEB3C3-2CB2-47B4-8C1F-D0C372F02F3CQ33679029-2675ABD7-D1F0-42B0-AF27-7DB9A310B177Q33689147-40CFD3D6-E89A-42EA-A648-D174DE34C105Q33872130-49C68854-225E-4607-8AC1-A61A7FC623AEQ33994261-040F7C73-34C6-4EA5-9E78-3A3D0E6B804BQ34384181-1F898610-B050-4E24-93DD-2672E77B1455Q34605896-5EDCE8D1-9306-4782-9CF7-14252B57B9BDQ34687332-0A972233-D769-44D5-92D0-0F12D83DBCE4Q34724711-911147D5-B1A3-4252-99D4-655DF3782DE2Q34764999-97BB7296-1611-406A-A2CD-EB823554C614Q34910419-22773D5C-015D-4FAC-B069-F9E00A422CEFQ35170024-517185D7-9D33-44F8-BA2A-3E3000F9829BQ35188878-EB424B46-E039-4F51-9162-FC6B7831E343Q35206971-593A1CB5-C206-4617-AD69-BB17864AAC61Q35208373-164A758E-EAE3-41AD-A96D-B01C27F34C08Q35699360-66B62FB6-06D0-4BA9-B4C9-95BE0746FF07Q35940690-F4A10820-4AC5-4857-A331-5A2FA32F9147Q35974778-03E1150E-44D1-4244-B42A-59AA17A18863Q36071390-2DED8616-7657-45F5-87A0-BC248C68BEB3Q36084891-9642E7A3-3F0A-466A-AD39-6DF478522FECQ36084943-0BA131BC-B675-4054-B0F1-D43B553F7708Q36412824-74002A05-112A-4CED-8063-F19BB0863E88Q36506677-1D5D38DB-A127-414A-AE53-A01C34F6F0C8Q36616642-7F817979-E315-4396-83D7-7B83CD941363Q36633267-B430B8DC-44D0-4C95-984C-63A25548D4FEQ36919959-E6235D54-6312-4660-9681-879C649DB6EEQ36961965-925172CD-C2F7-4CB0-BB2C-1E0C70E29AC0Q37057817-115D5E76-ED45-443E-9462-D1C3C8D0C84EQ37111489-10748C2A-1ECD-4302-96F2-D7E7CC211EB1Q37358254-A1FE90A9-5B7D-42C0-9966-4744CDDC8719Q37404770-B1635CE9-14CB-4AD6-9CEC-A9A809B31470Q37428259-4A6C3D10-7BD0-483A-B11A-EE04F15AC5D5
P2860
The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The first decade of biologic T ...... issues and future directions.
@en
The first decade of biologic T ...... issues and future directions.
@nl
type
label
The first decade of biologic T ...... issues and future directions.
@en
The first decade of biologic T ...... issues and future directions.
@nl
prefLabel
The first decade of biologic T ...... issues and future directions.
@en
The first decade of biologic T ...... issues and future directions.
@nl
P356
P1476
The first decade of biologic T ...... issues and future directions.
@en
P2093
Petros P Sfikakis
P304
P356
10.1159/000289205
P577
2010-02-18T00:00:00Z